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Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Background: Hypokalemia reduces the cardiac repolarization reserve. This prolongs the
QT-interval and increases the risk of ventricular arrhythmia; a risk that is exacerbated by
administration of classical class 3 anti-arrhythmic agents.Small conductance Ca2+-activated
K+-channels (KCa2) are a promising new atrial selective target for treatment of atrial
fibrillation. Under physiological conditions KCa2 plays a minor role in ventricular
repolarization. However, this might change under hypokalemia because of concomitant
increases in ventriculay -60r intracellur Ca2+.
Purpose: To study the effects of pharmacological KCa2 channel inhibition by the
compounds AP14145, ICA, or AP30663 under hypokalemic conditions as compared
to dofetilide and hypokalemia alone time-matched controls (TMC).
Methods: The current at +10 mV was compared in HEK293 cells stably expressing
KCa2.3 perfused first with normo- and then hypokalemic solutions (4 mM K
+ and 2.5 mM
K+, respectively). Guinea pig hearts were isolated and perfused with normokalemic (4 mM
K+) Krebs-Henseleit solution, followed by perfusion with drug or vehicle control. The
perfusion was then changed to hypokalemic solution (2.5 mM K+) in presence of drug. 30
animals were randomly assigned to 5 groups: ICA, AP14145, AP30663, dofetilide, or
TMC. QT-interval, the interval from the peak to the end of the T wave (Tp–Te), ventricular
effective refractory period (VERP), arrhythmia score, and ventricular fibrillation (VF)
incidence were recorded.
Results: Hypokalemia slightly increased KCa2.3 current compared to normokalemia.
Application of KCa2 channel inhibitors and dofetilide prolonged the QT interval corrected
for heart rate. Dofetilide, but none of the KCa2 channel inhibitors increased Tp–Te during
hypokalemia. During hypokalemia 4/6 hearts in the TMC group developed VF (two
spontaneously, two by S1S2 stimulation) whereas 5/6 hearts developed VF in the
dofetilide group (two spontaneously, three by S1S2 stimulation). In comparison, 0/6, 1/in.org May 2020 | Volume 11 | Article 7491
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Frontiers in Pharmacology | www.frontiers6, and 1/6 hearts developed VF when treated with the KCa2 channel inhibitors AP30663,
ICA, or AP14145, respectively.
Conclusion: Hypokalemia was associated with an increased incidence of VF, an effect
that also seen in the presence of dofetilide. In comparison, the structurally and functionally
different KCa2 channel inhibitors, ICA, AP14145, and AP30663 protected the heart from
hypokalemia induced VF. These results support that KCa2 inhibition may be associated
with a better safety and tolerability profile than dofetilide.Keywords: KCa2 channel inhibitor, hypokalemia, dofetilide, Kv11.1 blockers, SK channel, SK channel inhibitor,
arrhythmia, antiarrhythmic drugINTRODUCTION
Intra- and extra-cellular K+ concentrations are closely regulated
physiologically. Hypokalemia, defined as K+ serum levels below
3.5 mM, has been reported to occur in 16% of patients when first
admitted to acute medical departments (Jensen et al., 2015).
Hypokalemia is an adverse effect of diuretic therapy prescribed to
treat hypertension, heart failure and other conditions, but can
also develop from e.g. vomiting and diarrhea. Hypokalemia
lowers the Na/K-ATPase activity, hyperpolarizes the resting
membrane potential, and despite increasing the driving force
for outward K+ current it suppresses the cardiac IK1, IKr, and Ito
currents. This reduction in the repolarizing reserve in turn
prolongs the cardiac action potential, and promotes the
development of early-after depolarizations (EAD) and
initiation of ventricular tachycardia (VT) (for review see
(Weiss et al., 2017)). Moreover, action potential prolongation
and hypokalemia increase intracellular Ca2+ loading through
increased Ca2+ influx via calcium channels, and by lowered Na+/
Ca2+ activity (calcium efflux) secondary to the reduced Na+/K+-
ATPase activity and consequent elevated intracellular Na+
concentrations (Aronsen et al., 2015; Weiss et al., 2017). It has
been suggested that the increase in intracellular calcium activates
ventricular KCa2 channels, functioning as a protective
mechanism against ventricular arrhythmia during hypokalemia
(Chan et al., 2015). If that is the case, KCa2 channel inhibition
should be proarrhythmic under hypokalemic conditions. The
KCa2 channel also known as the small conductance calcium
activated K+, or SK, channel is a novel drug target for treatment
of atrial fibrillation (AF) (Diness et al., 2010; Qi et al., 2014;
Skibsbye et al., 2014; Haugaard et al., 2015; Diness et al., 2017).
Under physiological conditions KCa2 channels appear to play a
minor role in ventricular repolarization. However, this might
change under pathophysiological conditions such as heart failure
and myocardial infarction or hypokalemia (Chua et al., 2011;
Chang et al., 2013a; Chang et al., 2013b; Gui et al., 2013; Bonilla
et al., 2014; Chan et al., 2015; Hundahl et al., 2017).
Classical class III anti-arrhythmic drugs such as sotalol and
dofetilide inhibit KV11.1 thereby reducing IKr and prolonging the
QT-interval (Redfern et al., 2003). The drug-induced
impairment of the repolarizing reserve and consequent risk for
ventricular arrhythmia is further potentiated by hypokalemia
(McKibbin et al., 1984).in.org 2Because hypokalemia increases intracellular calcium and
compromises the repolarizing reserve, we hypothesized that
inhibition of KV11.1 and KCa2 would be pro-arrhythmic in a
hypokalemic setting. To study this we investigated the effects of
KCa2 channel inhibition under hypokalemic conditions as
compared to the class III anti-arrhythmic agent dofetilide.
Moreover, we also explored if KCa2.3 channel conductance per
se is affected by hypokalemia.MATERIALS AND METHODS
Electrophysiology
The experiments were performed on HEK293 cells stably
expressing KCa2.3. The cells were cultured in Dulbecco’s
modified Eagle ’s medium (DMEM1965, Substrat- og
sterilcentralen, University of Copenhagen, Denmark)
supplemented with 10% fetal bovine serum (Biowest, France),
100 U/ml of penicillin/streptomycin (Sigma, Germany), and 100
µg/ml geneticin (Gibco, USA).Whole cell patch clamping was
performed on an automated whole-cell patch-clamp system
(QPatch 16 HT) with single-hole Qplates (Sophion, Denmark).
The Qpatch automatically generates giga seals, whole-cell
formation, compound application, voltage-clamping, and
recording of current. On the day of experiment, HEK293 cells
expressing human KCa2.3 were treated with detachin (Genlantis,
CA, USA) and resuspended in serum Free medium (C5467
SAFC, Buchs, Switzerland) containing 25 mM HEPES 0.04
mg/ml soy bean trypsin inhibitor (T6522 Sigma) and 100U/ml
penicillin/streptomycin.
The extracellular solution consisted of (in mM): NaCl 145;
CaCl2 2; MgCl2 1; 10 HEPES and 10 glucose and 4 mM KCl or
2.5 mM KCl for the normo- and hypokalemic conditions. The
pH was adjusted to 7.4 with NaOH. The intracellular solution
contained (in mM): 154 KCl, 10 mM HEPES and 10 mM EGTA.
CaCl2 was added to give calculated free concentrations of Ca
2+ of
0.4 µM (K0.4) and MgCl2 was added to give a free concentration of
1 mM. Free concentrations were calculated by the Eqcal software.
Currents were elicited by a voltage ramp from −140 mV to
+20 mV (200 ms in duration) applied every fifth second from a
holding potential of −80 mV. Data were sampled at 10 kHz, four-
order Bessel filter, cutoff frequency 3 kHz, and 80 % Rs
compensation. The currents were recorded for 500 s inMay 2020 | Volume 11 | Article 749
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extracellular solution for 200 s.
Isolated Perfused Guinea Pig Heart
Experiments
Guinea pig experiments were performed under licenses from the
Danish Ministry of justice (2018-15-0201-01430 and 2016-15-
0201-00850) and in accordance with the Danish guidelines for
animal experiments according to the European Commission
Directive 86/609/EEC.
30 female Guinea pigs (weighing between 350 and 600 g)
from the Dunkin Hartley strain (HsdPoc : DH) (Charles River,
Scanbur A/S, Karlslunde, Denmark) were used for the study, and
randomized to a hypokalemia alone time-matched control group
(TMC) or groups of n = 6 treated with ICA, AP14145, AP30663,
or dofetilide. The animals were anaesthetized (200 mg/kg
pentobarbital and lidocaine hydrochloride 0.150 ml/100 g body
weight i.p., (Glostrup Apotek, Denmark)), and a dose of 1000 IU/
kg heparin was injected intravenously. After artificial ventilation
was established (volume, 12 ml/kg; rate, 60 strokes/min) a
thoracotomy was performed. The perfusion cannula was
inserted and fixed in the aorta for retrograde perfusion with
(normokalemic) Krebs-Henseleit solution: (in mM L−1: NaCl
120.0, NaHCO3 25.0, KCl 4.0, MgSO4 0.6, NaH2PO4 0.6, CaCl2
2.5, glucose 11.0, saturated with 95% O2 and 5% CO2, 37°C, pH
7.4). Hearts were then mounted in a Langendorff set-up (Hugo
Sachs Elektronik, Harvard Apparatus GmbH, Germany) and
perfused at a constant perfusion pressure of 60 mmHg.
Electrocardiography (ECG) was measured with three ECG
electrodes placed close to the heart. A pacing electrode was
placed on the left ventricle. All data were acquired at 2 KHz using
the 16-channel PowerLab system (ADInstruments, Oxford, UK),
and monitoried by LabChart 7 software (ADInstruments).
After stabilization, the heart was subjected to three
subsequent 20-min perfusion periods (Figure 1): 1) baseline
recording in normokalemia (4 mM K+), 2) drug (ICA, AP14145,
AP30663, dofetilide, or DMSO) + normokalemia, and 3) drug +
hypokalemia (2.5 mM K+). At the end of each perfusion period
ventricular effective refractory period (VERP) was measured by
applying electrical stimulation (five times rheobase) with a fixed
interval of 200 ms (S1S1 stimulation) and for every 10th beat an
extra stimulus (S2) was applied with 10 ms decrements starting
from 150 ms. The VERP was defined as the longest S1–S2
interval failing to elicit a ventricular action potential. Between
the VERP recordings, the heart was kept unpaced. QT-intervals
and the intrinsic heart rate (HR) were analyzed just prior to
electrical stimulation (mean of 100 last beats).
Arrhythmia Scoring
The ECG recordings from the three perfusion periods were
analyzed for the incidence of ventricular extra systoles (VES)
and occurrence of bi-, tri-, and quadrigeminy, VT, and
ventricular fibrillation (VF). VT was defined as six or more
consecutive VES with an increased HR of >50 beats per minute
(bpm). Non-sustained VT (NSVT) < 30 beats; sustained VT
(SVT) > 30 beats.Frontiers in Pharmacology | www.frontiersin.org 3A predefined arrhythmia score system was used to score the
severity of the arrhythmia see Table 1. The arrhythmia score was
the sum of the individual scores.
Data Analysis
All data and figures were analyzed using Prism 8 (GraphPad
Software, CA, USA).FIGURE 1 | Flowchart of isolated perfused guinea pig experiments and the
five experimental groups (TMC, Dofetilide, ICA, AP14145, and AP30663).
Three 20-min perfusion periods: baseline, drug, and drug + hypokalemia. VF
induction by electrical stimulation (S1–S2) was attempted at the end of each
period. TMC, time-matched control; VF, ventricular fibrillation.May 2020 | Volume 11 | Article 749
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removing outliers by ROUT testing (Q = 10%), a paired
Wilcoxon test was used to compare the currents during
normo- and hypokalemia.
QT-intervals were corrected for HR using the guinea pig
specific HR QT correction formula: QTcH = QT/(RR/0.28)0.7861
(Holzgrefe et al., 2014).
Changes from baseline values were compared between each
drug group with the TMC group for HR, QTcH, the interval
from the peak to the end of the T wave (Tp–Te), VERP, and
arrhythmia score by using two-way ANOVA or, in case of
missing values, a mixed-effects analysis with Sidak’s multiple
comparisons post hoc test. P values are given with three decimals.RESULTS
Effects of Hypokalemia on outward K+
KCa2.3 Currents
To investigate whether there was a direct effect on KCa2.3 current as
a consequence of change in extracellular K+ a number of patch-
clamp experiments on heterologously expressed KCa2.3 channelsFrontiers in Pharmacology | www.frontiersin.org 4were conducted. As expected from the Nernst equation, when
switching from 4 mM to 2.5 mM extracellular K+, the voltage at
0 current was shifted toward more hyperpolarized potentials (from
−80.23 ± 1.22 to −87.13 ± 1.75 mV, p < 0.001, n = 10) (Figure 2A),
and based on this, a higher driving force for K+-efflux from the cell
at +20 mV is achieved. There was slightly more current at +20 mV
during hypokalemia than during normokalemia (181 ± 44 pA/pF vs
154 ± 32 pA/pF, Figure 2B).
Effects of Hypokalemia on Repolarization,
Heart Rate, and Ventricular Refractoriness
A total of 30 animals were included in the study and randomly
assigned to 5 groups: ICA, AP14145, AP30663, dofetilide, or TMC.
Despite randomization there were baseline differences in QTcH
and HR between the groups (Figure 3). Therefore we evaluated the
effect of drugs by comparing changes from baseline (D-change =
drug-baseline) between TMC and treatment groups for both
perfusion periods (drug and drug + hypokalemia) (Table 2).
The effects of hypokalemia (2.5 mM K+) versus
normokalemia (4.0 mM K+) were studied in the TMC group.
The QTcH at baseline was 138 ± 3 ms during normokalemia and
130 ± 10 ms during hypokalemia (Figure 3A, Table 2). There
was also no effect on HR (Figure 3B, Table 2). While no effects
on QT and VERP were observed, the dispersion of ventricular
repolarization marked by the Tp–Te interval was increased from
17 ± 2 ms during baseline to 38 ± 9 ms during hypokalemia
(Figure 3, Tables 2 and 3) and a ventricular impact of
hypokalemia was clearly visible by the increased incidence of
arrhythmia (Figure 4). The small impact of hypokalemia on QT
and the increased arrhythmia susceptibility reflect what has been
previously reported in guinea pigs (Osadchii and Olesen, 2009).
Effects of Kv11.1 or KCa2 Inhibition on
Repolarization, HR, and Ventricular
Refractoriness
During normokalemia, dofetilide and AP30663 both increased
QTcH versus baseline compared with TMC (Table 2, Figure
3A). The KCa2 channel inhibitor ICA increased QTcH versusTABLE 1 | Arrhythmia scoring.
Arrhythmia Score
<5 ventricular extra systoles (VES) 0
5-25 VES 1
>25 VES 2
Bigeminy 3
Non-sustained ventricular tachycardia (NSVT) 4
Sustained ventricular tachycardia (SVT) 5
Induced ventricular fibrillation (VF) 10
Spontaneous VF 15The number of VES was counted during the last unpaced 5 min of perfusion period one
and two and during the last 15 min of hypokalemia + drug (T45–T60). The occurrence of
bi-, or tri-, or quadri-geminy, NSVT, SVT, induced and spontaneous VF were counted
during the entire perfusion period. Induced VF refers to when VF was induced by
incremental S1S2 stimulation during VERP determination.A B
FIGURE 2 | Hypokalemia shifts the reversal potential of K+ in HEK cells expressing KCa2.3. (A) Current–voltage relationship of KCa2.3 current measured at 4.0 mM
extracellular K+ and at 2.5 mM K+. Currents were elicited by a voltage-ramp protocol from −140 to +20 mV (200 ms). (B) Summary graph showing the individual
current levels at 2.5 mM and 4.0 mM K+, n = 10. Bars represent the mean values.May 2020 | Volume 11 | Article 749
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TMC. However, none of the KCa2 channel inhibitors nor
dofetilide affected the Tp–Te interval during normokalemia
compared to the TMC group (Table 2).Frontiers in Pharmacology | www.frontiersin.org 5Dofetilide, AP30663, and ICA all decreased HR versus
baseline compared with TMC (Table 2, Figure 3B).
The VERP at a paced HR of 300 bpm, was increased by the
KCa2 channel inhibitors AP30663 and ICA, but not by the Kv11.1A
B
C
FIGURE 3 | KCa2 channel inhibitors prolong QTc and Tp-Te intervals, and decrease heart rate to a variable degree. (A) Changes in the QT interval corrected for heart
rate (QTcH) (B) Changes ins the Tp-Te interval and (C) heart rate in the five groups. Data are presented as mean ± SEM. For QTc and heart rate: N = 6 except for
measurement during hypokalemia where n = 5 for ICA and n = 4 for TMC and dofetilide because of spontaneous ventricular fibrillation. TMC, time-matched control.TABLE 2 | Changes (Ddrug − baseline; Ddrug + hypo − baseline) in QTcH, and HR for each group.
Drug/vehicle
D-QTcH
n; p-
value
Drug/vehicle +
hypo D-QTcH
Drug D-
HR
n, p-
value
Drug/vehicle +
hypo D-HR
n; p-
value
Drug D-
Tp–Te
n, p-
value
Drug/vehicle
+hypo D-Tp–Te
n; p-
value
TMC −1 ± 2 6; NA −5 ± 7 −1 ± 2 6; NA −9 ± 3 4; NA 5 ± 3 6; NA 21 ± 7 6; NA
3 nM
Dofetilide
17 ± 3 6; 0.016 32 ± 11 −21 ± 5 6; 0.017 −29 ± 7 4; 0.055 14 ± 5 6; 0.725 57 ± 18 4; 0,015
3 µM ICA 9 ± 3 6; 0.250 24 ± 6 −18 ± 3 6; 0.040 −23 ± 8 5; 0.265 11 ± 4 6; 0.925 31 ± 9 5; 0,766
3 µM
AP14145
2 ± 3 6; 0.921 5 ± 4 −10 ± 7 6; 0.480 −19 ± 5 6; 0.537 4 ± 5 6; > 0.999 6 ± 8 6; 0,434
3 µM
AP30663
15 ± 3 6; 0.036 21 ± 3 −18 ± 3 6; 0.044 −38 ± 4 6; 0.001 5 ± 2 6; > 0.999 12 ± 9 6; 0,777May 2020 | Volume 11 | AP-values refer to the comparison of D-values between TMC and treatment groups.
QTcH, QT interval corrected for heart rate; HR, heart rate; Tp–Te, the interval from the peak to the end of the T wave.rticle 749
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significantly change QTcH, VERP, or HR versus baseline when
compared to TMC.
Effects of KCa2 or Kv11.1 Inhibition on
Ventricular Refractoriness and
Repolarization and on HR During
Hypokalemia
During hypokalemia dofetilide, AP30663, and ICA all continued
to increase QTcH versus baseline compared with TMC (Table 2,
Figure 3A). Interestingly, dofetilide increased the dispersion of
ventricular repolarization during hypokalemia even more than
hypokalemia alone; the Tp–Te increase from baseline was 57 ±
18 ms compared to the increase seen in the TMC group which
was increased by 21 ± 7 ms by hypokalemia. None of the KCa2
channel inhibitors affected Tp–Te during hypokalemia
compared to the TMC group.
In the TMC group the HR was decreased during
hypokalemia, and the decrease in HR versus baseline seen by
dofetilide and ICA during hypokalemia was no longer
significantly different from the decrease of HR in the TMC
group during hypokalemia (Table 2, Figure 3B). The KCa2
channel inhibitor AP30663 decreased the HR to a degree that
was greater than the decrease in the TMC group.Frontiers in Pharmacology | www.frontiersin.org 6The VERP at a paced HR of 300 bpm, was increased by the
KCa2 channel inhibitors AP30663 and ICA (Table 3, Figure 4).
However, due to induction of VF in the 4/6 hearts during
hypokalemia in the TMC group before the VERP could be
established, the statistical comparison to the TMC group
should be taken with a grain of salt. In the dofetilide group,
VF was induced in 5/6 hearts before VERP could be established
during hypokalemia. The one dofetilide heart without VF
induction had a baseline VERP of 120 which was markedly
higher than the mean of the other 5 dofetilide hearts at baseline
(76 ± 4 ms). In this particular heart the VERP could not be
measured during normokalemia since it could not be paced at a
constant rate of 300 bpm. During hypokalemia, however, the
VERP remained unchanged from the baseline value of 120 ms.
The KCa2 channel inhibitor AP14145 neither changed QTcH,
VERP, or HR versus baseline when compared to TMC during
hypokalemia as was the case during normokalemia.
KCa2 Channel Inhibition Decreased the
Risk of Ventricular Arrhythmia
Hypokalemia increased the incidence of ventricular arrhythmia
in the TMC group. Further impairment of the repolarizing IKr
current by dofetilide resulted in VF in five out of six animals.
Two of them developed spontaneously, one before hypokalemiaFIGURE 4 | The ventricular effective refractory period (VERP) in the hypokalemia alone time-matched control (TMC) group as well as in the dofetilide group and three
KCa2 channel inhibitor groups at three time points. The number of data points for each time point are given in each graph. VERP could not be measured in all cases
during hypokalemia due to the presence of ventricular fibrillation.TABLE 3 | Changes (Ddrug − baseline; Ddrug + hypo − baseline) in VERP for each group.
Drug/vehicle
D-VERP
n, p-value Drug/vehicle+hypo
D-VERP
n, p-value
TMC −2 ± 2 6 −5 ± 5 2
3 nM Dofetilide 4 ± 7 4, 0.846 0 ± 0 1, 0.970
3 µM ICA 13 ± 3 6, 0.061 0 ± 4 5, 0.867
3 µM AP14145 8 ± 5 6, 0.308 10 ± 8 5, 0.231
3 µM AP30663 17 ± 3 6, 0.016 15 ± 2 6, 0.058May 2020 | Volume 11 |P-values refer to the comparison of D-values between TMC and treatment groups.Article 749
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receiving KCa2 inhibitors only presented with VF in 1/6 (ICA
and AP14145) or 0/6 (AP30663) (Figure 3).
The presence of VF versus no VF was matched by the
arrhythmia scores in the different groups: The TMC and
dofetilide were not significantly different, whereas all KCa2
channel inhibitors resulted in a lower arrhythmia score, both
before and during hypokalemia as compared to the TMC group
(Figure 5, Table 4).DISCUSSION
Hypokalemia was associated with an increased incidence of
ventricular arrhythmia. This was also seen in the presence of
the class III anti-arrhythmic agent dofetilide. On the contrary,
the incidence of ventricular arrhythmias during hypokalemiaFrontiers in Pharmacology | www.frontiersin.org 7was reduced in the presence of three structurally and functionally
different KCa2 channel inhibitors, ICA, AP14145, and AP30663.
Effects of Induced Hypokalemia at the
Cellular Level
Hypokalemia suppresses the cardiac IK1, IKr, and Ito current even
though the electrical driving force for K+ efflux is increased. This
is because lowered extracellular K+ concentrations speeds up the
inactivation of IKr and slows the recovery from inactivation of
Ito (Sanguinetti and Jurkiewicz, 1992; Firek and Giles, 1995;
Yang et al., 1997) and stabilizes the blocking cations (e.g. Mg2+
and polyamines) in the pore of the Kir2.1 (IK1) channel [for
review see (Nichols and Lopatin, 1997)], thereby decreasing the
repolarizing outward K+ currents. Whether human KCa2
channels are affected by small changes in extracellular K+ is
unknown. Like the Kir2.1 channel, the rat KCa2 channel is also
inwardly rectifying partly as a result of voltage-dependentA
B C
FIGURE 5 | KCa2 channel inhibitors reduces the incidence of ventricular arrhythmia. (A) Incidence of ventricular fibrillation (VF) in the five groups. (B) ECG examples of
arrhythmias recorded during hypokalemia + 3 nM Dofetilide. (C) Arrhythmia score for the five groups for each perfusion period (n = 6, data are presented as mean ± SEM).
ECG, electrocardiography.TABLE 4 | Changes (Ddrug − baseline; Ddrug + hypo − baseline) in arrhythmia-score for each group.
Drug
D-arrhythmia score
p-Value Drug + hypo
D-arrhythmia score
p-Value
TMC 5 ± 4.1 NA 11.8 ± 3.2 NA
3 nM Dofetilide 2.7 ± 2.1 0.896 13.8 ± 1.8 0.937
3 µM ICA −4 ± 1.2 0.028 −0.1 ± 2 0.002
3 µM AP14145 −4 ± 1.5 0.036 0.3 ± 3.2 0.005
3 µM AP30663 −3.2 ± 1.4 0.065 −2.7 ± 1.5 <0.001May 2020 | Volume 11 | AP-values refer to the comparison of D-values between TMC and treatment groups. N = 6 for all groups.rticle 749
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Moreover, as for the Kir2.1 this block is increased at lower
extracellular K+ concentration, effectively lowering the KCa2
current (Soh and Park, 2001). In the present study we were
unable to clearly demonstrate that outward human KCa2.3
current was inhibited by lowering the extracellular K+
concentration from 4 mM to 2.5 mM. The discrepancy
between our recordings and the study by Soh et al. is likely
because we addressed the effects of much smaller changes in
extracellular K+, but it could also stem from species or KCa
subtype differences. In any case, cardiac KCa2 current will not
only be inhibited by hypokalemia via changes in cation block, but
also activated by the concomitant increase in intracellular Ca2+
that occurs during hypokalemia. During hypokalemia the
prolonged action potential duration and lowered Na+/Ca2+
activity increase intracellular Ca2+ concentrations (Aronsen
et al., 2015; Weiss et al., 2017). It has been suggested that this
increase in intracellular calcium activates ventricular KCa2
channels, functioning as a protective mechanism against
ventricular arrhythmia during hypokalemia (Chan et al., 2015).
We addressed this hypothesis in the current study by performing
experiments on isolated perfused guinea pig hearts. Lowering the
extracellular K+ concentration to 2.5 mM resulted in minor
changes of ventricular repolarization but a marked increased
risk of ventricular tachycardia, which is similar to what has
previously been observed in guinea pigs (Osadchii and Olesen,
2009; Osadchii et al., 2009). That hypokalemia did not produce
larger changes in ventricular repolarization is likely explained by
the fact that repolarization of ventricular action potential in
guinea pigs is more dependent on the IKs (KV7.1/KCNE1)
current as compared to IKr (KV11.1) (O’Hara and Rudy, 2012).
Application of the class III anti-arrhythmic agent dofetilide
did not prevent ventricular arrhythmia. If anything, dofetilide
slightly exacerbated the ventricular arrhythmia, however not to
any statistically significant extent. In contrast, the KCa2 channel
pore blocker ICA and the negative allosteric modulators of the
KCa2 channel AP14145 and AP30663 significantly reduced the
ventricular arrhythmia score and the incidence of VF, thereby
suggesting that KCa2 channel inhibition protected the ventricles
from hypokalemia induced arrhythmia.
In this study we observed QTcH prolongations by AP30663
and ICA, but not with AP14145, and both also seemed to
prolong the VERP. None of the KCa2 channel inhibitors
affected the Tp–Te interval indicating no effects on the
dispersion of ventricular repolarization. In comparison, in the
guinea pig heart dofetilide prolonged both QTcH and the Tp–Te
interval but did not increase the VERP in the few VERP
determinations that were possible to complete. Interestingly,
the only heart in the dofetilide group in which VF was not
induced had a markedly higher baseline VERP than the rest of
the group.
Based on these few observations and the KV11.1 selectivity
profile of ICA and AP30663 (IC50 > 32 µM and 4–15 µM
respectively (Skibsbye et al., 2014; Bentzen et al., 2020), we
speculate that the increase of the QTcH and VERP are mainly
but not completely caused by ventricular KCa2 inhibition.Frontiers in Pharmacology | www.frontiersin.org 8Moreover, one could speculate that the pure KV11.1-driven
prolongation of the QTcH and Tp–Te interval observed caused
by dofetilide was pro-arrhythmic, during hypokalemia, whereas a
KCa2-driven prolongation of the QTcH with no effects on the
Tp–Te interval appeared to protect the heart from ventricular
arrhythmia. The anti-arrhythmic effects and our findings of
small increases in QT and VERP (~5–20 ms) support a role of
KCa2 channels in the guinea pig ventricle, albeit minor under
physiological conditions, which is in line with our previous
studies demonstrating the expression of KCNN2 and KCNN3
in guinea pig ventricular tissue and ventricular anti-arrhythmic
effects of KCa2 channel inhibitors (Diness et al., 2015; Kirchhoff
et al., 2019).
However, the effect of KCa2 channel inhibition on atrial
refractoriness has consistently been found to be greater than the
ventricular effects and hence KCa2 channels seem to show
functional atrial selectivity (Diness et al., 2010; Qi et al., 2014;
Diness et al., 2017; Kirchhoff et al., 2019; Bentzen et al., 2020;
Diness et al., 2020). Our data during hypokalemia are different
from the findings by Chan et al. who suggested that KCa2 channel
inhibition by the toxin apamin facilitated VF induction (Chan
et al., 2015) in rabbits. Differences in species and methodology
might explain this discrepancy, since they used rabbits, and
optical mapping. Another difference between our study and that
of Chan that could explain some of the discrepancies is the use of
the pore blocking peptide apamin versus our three small molecule
KCa2 inhibitors of which two (AP30663 and AP14145) are
negative allosteric modulators and one (ICA) is a pore blocker.
Furthermore, AP14145 and AP30663 in higher concentrations
(10 µM) also inhibit the late NaV1.5 current (Bentzen et al., 2020).
Hypokalemia-induced increased intracellular Ca2+ has been
proposed to activate Ca2+-calmodulin kinase thereby inducing
late Na+ currents and facilitating arrhythmia (Pezhouman et al.,
2015). We do not know whether this could add to the anti-
arrhythmic effects and/or to a modification of the increase in
QTcH observed under hypokalemia of these two drugs.
In a recent study, Tazmini et al. explored the cellular
mechanisms behind ventricular and atrial arrhythmias during
hypokalemia and found that hypokalemia induced Ca2+ overload,
Ca2+ waves, and both early and delayed afterdepolarizations in
both ventricular and in atrial cells which contain t-tubules
(Tazmini et al., 2020). On the contrary, calcium was not
important for development of early afterdepolarizations in atrial
cardiomyocytes lacking t-tubules. In the present study we did not
observe any hypokalemia induced AF episodes and based on the
findings of Tazmini et al. it would be interesting to investigate if
KCa2 channel inhibition plays a role in this.
Three Different KCa2 Inhibitors—
Similarities and Differences
We studied three structurally and functionally different KCa2
channel inhibitors, the pore blocker ICA, and the two negative
allosteric modulators of KCa2 channels AP14145 and AP30663,
which inhibit the KCa2 channel by shifting the calcium activation
curve to higher intracellular calcium concentrations. They all
prolong the QTc (2-15 ms), and VERP but to varying degrees,May 2020 | Volume 11 | Article 749
Diness et al. KCa2 Channel Inhibition During Hypokalemmiawith AP30663 showing the largest prolongation. Interestingly
despite differences in mechanism of inhibition and effects on
QTc all significantly reduced and prevented the incidence of VF
during hypokalemia.CONCLUSIONS
Induced hypokalemia was associated with an increased risk of
spontaneous or induced ventricular arrhythmia and VF, a risk
that was also seen after administration of dofetilide. In contrast,
the structurally and functionally different KCa2 channel
inhibitors, ICA, AP14145, and AP30663 decreased this risk
and prevented hypokalemia-induced VF. These results support
that the KCa2 inhibitors, particularly AP30663, may be associated
with a better safety and tolerability profile than dofetilide.DATA AVAILABILITY STATEMENT
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